Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of FOXM1 as a novel protein biomarker and therapeutic target for colorectal cancer progression: Evidence from immune infiltration and bioinformatic analyses.
Natarajan SR, Krishnamoorthy R, Alshuniaber MA, Al-Anazi KM, Farah MA, Rajagopal P, Palanisamy CP, Veeraraghavan VP, Jayaraman S. Natarajan SR, et al. Among authors: rajagopal p. Int J Biol Macromol. 2024 Dec;282(Pt 4):137201. doi: 10.1016/j.ijbiomac.2024.137201. Epub 2024 Nov 1. Int J Biol Macromol. 2024. PMID: 39489237
(5E,7E)-4,5,6 Trihydroxy-3-(hydroxymethyl)tetrahydro-2H-pyran-2-ylheptadeca-5,7-dienoate from Euclea crispa (L.) Inhibits Ovarian Cancer Cell Growth by Controlling Apoptotic and Metastatic Signaling Mechanisms.
Palanisamy CP, Cui B, Zhang H, Jayaraman S, Rajagopal P, Veeraraghavan VP. Palanisamy CP, et al. Among authors: rajagopal p. Bioinorg Chem Appl. 2022 Jan 29;2022:4464056. doi: 10.1155/2022/4464056. eCollection 2022. Bioinorg Chem Appl. 2022. Retraction in: Bioinorg Chem Appl. 2023 Oct 4;2023:9854717. doi: 10.1155/2023/9854717 PMID: 35132312 Free PMC article. Retracted.
A review on advancements in the application of starch-based nanomaterials in biomedicine: Precision drug delivery and cancer therapy.
Pei J, Yan Y, Jayaraman S, Rajagopal P, Natarajan PM, Umapathy VR, Gopathy S, Roy JR, Sadagopan JC, Thalamati D, Palanisamy CP, Mironescu M. Pei J, et al. Among authors: rajagopal p. Int J Biol Macromol. 2024 Apr;265(Pt 1):130746. doi: 10.1016/j.ijbiomac.2024.130746. Epub 2024 Mar 10. Int J Biol Macromol. 2024. PMID: 38467219 Review.
Molecular analysis to identify novel potential biomarkers as drug targets in colorectal cancer therapy: an integrated bioinformatics analysis.
Gatasheh MK, Natarajan SR, Krishnamoorthy R, Alsulami TS, Rajagopal P, Palanisamy CP, Veeraraghavan VP, Jayaraman S. Gatasheh MK, et al. Among authors: rajagopal p. Mol Cell Oncol. 2024 Mar 18;11(1):2326699. doi: 10.1080/23723556.2024.2326699. eCollection 2024. Mol Cell Oncol. 2024. PMID: 38505173 Free PMC article.
Identifying the molecular mechanisms of action of wound healing properties of Mathan tailam and Mahamegarajanga tailam in Wistar albino rats: Evidence through IL-10/VEGF/TNF-α signalling pathways.
Senthilnathan S, Rajagopal P, Krishnamoorthy R, Alshuniaber MA, Al-Anazi KM, Farah MA, Jayaraman S, Veeraraghvan VP, Gnanamani A. Senthilnathan S, et al. Among authors: rajagopal p. Acta Trop. 2024 Oct;258:107357. doi: 10.1016/j.actatropica.2024.107357. Epub 2024 Aug 8. Acta Trop. 2024. PMID: 39122101
A Comprehensive Review on Therapeutic Perspectives of Phytosterols in Insulin Resistance: A Mechanistic Approach.
Prasad M, Jayaraman S, Eladl MA, El-Sherbiny M, Abdelrahman MAE, Veeraraghavan VP, Vengadassalapathy S, Umapathy VR, Jaffer Hussain SF, Krishnamoorthy K, Sekar D, Palanisamy CP, Mohan SK, Rajagopal P. Prasad M, et al. Among authors: rajagopal p. Molecules. 2022 Feb 28;27(5):1595. doi: 10.3390/molecules27051595. Molecules. 2022. PMID: 35268696 Free PMC article. Review.
190 results